The STEP trials showed continued weight loss improvement at higher doses, with the dose-response relationship remaining positive through 2.4 mg
c ch sc t melanin gy ra vt thm, nm, tn nhang
For patients with gastroparesis, however, further slowing of already-delayed gastric emptying may worsen symptoms like nausea, vomiting, early fullness, and bloating
It is important to understand that Mounjaro is not suitable for everyone, and it must only be used following a full clinical assessment
A randomized, open-label, multicenter, 4-week study to evaluate the tolerability and pharmacokinetics of ITCA 650 in patients with type 2 diabetes